Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancer
about
Quantitative proteomics by SWATH-MS reveals sophisticated metabolic reprogramming in hepatocellular carcinoma tissues.Cellular glycosylation senses metabolic changes and modulates cell plasticity during epithelial to mesenchymal transition.Pharmacological inhibition of CaMKK2 with the selective antagonist STO-609 regresses NAFLD.Shared and distinct lipid-lipid interactions in plasma and affected tissues in a diabetic mouse model.Delineation of the androgen-regulated signaling pathways in prostate cancer facilitates the development of novel therapeutic approaches.Hexosamine Biosynthetic Pathway Inhibition Leads to AML Cell Differentiation and Cell Death
P2860
Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancer
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Inhibition of the hexosamine b ...... tion-resistant prostate cancer
@en
type
label
Inhibition of the hexosamine b ...... tion-resistant prostate cancer
@en
prefLabel
Inhibition of the hexosamine b ...... tion-resistant prostate cancer
@en
P2093
P2860
P50
P356
P1476
Inhibition of the hexosamine b ...... tion-resistant prostate cancer
@en
P2093
Adam T Szafran
Alexander Zaslavsky
Ali Shojaie
Arul M Chinnaiyan
Arun Sreekumar
Ayesha S Khan
David A Bader
Dean P Edwards
Efrosini Tsouko
Fabio Stossi
P2860
P2888
P356
10.1038/NCOMMS11612
P407
P577
2016-05-19T00:00:00Z